Posted by: youngragingbull | May 27, 2013

Valeant to buy eye-care firm for $8.7B

Canadian pharmaceutical giant Valeant has agreed to buy eye care product maker Bausch + Lomb for $8.7 billion, the two companies announced Monday.

Laval, Que.-based Valeant will acquire Bausch & Lomb in a transaction that Valeant says will achieve $800 million in cost savings by the end of next year.

Bausch + Lomb has numerous eye care product lines, including contact lenses, surgical goggles and eye drops. The company expects to take in $3.3 billion next year across all of its product lines.

Valeant will finance the transaction through a combination of debt and up to $2 billion of new shares.

In afternoon trading on the TSX, shares of Valeant jumped more than 10% to an all-time high of $95.82 as investors cheered the transaction.

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s


%d bloggers like this: